Literature DB >> 9794911

Splenorenal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats.

P Calès1, F Oberti, N Veal, J Fort, M Kaassis, F Moal, C Aubé, E Vuillenin, C Pilette, H Rifflet, R Trouvé.   

Abstract

The aim of this study was to develop a technique that could serve as an index of portosystemic shunt (PSS) blood flow in portal hypertensive rats whose main shunt is the splenorenal shunt (SRS). The main hemodynamic measurements performed were: SRS blood flow by the transit-time ultrasound (TTU) method, percentage of PSS, and regional blood flows by the microsphere method. We determined the accuracy and reproducibility of SRS blood flow measurements under baseline and pharmacological (octreotide) conditions. SRS blood flow was compared with other hemodynamic characteristics. Two models of portal hypertension were used: secondary biliary and dimethylnitrosamine cirrhosis. The SRS blood flow was correlated with mesenteric (r = .76; P < .001) and splenic (r = .67; P < .01) PSS percentages. The intra- and interobserver agreements for SRS blood flow were excellent: ric = .99 and ric = .98, respectively. SRS blood flow was six times higher in portal hypertensive rats (0.6 +/- 0.7 mL . min-1 . 100 g-1) than in sham rats (0.1 +/- 0.1 mL . min-1 . 100 g-1 [P < .01]). Octreotide significantly decreased SRS blood flow but not mesenteric or splenic PSS percentages. SRS is the main PSS in rats. The measurement of SRS blood flow by TTU is accurate and reproducible. This method can be used to identify new mechanisms in hemodynamic studies that differ from those identified by the measurement of the percentage of PSS by the microsphere method, especially in pharmacological studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794911     DOI: 10.1002/hep.510280515

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.

Authors:  Lionel Fizanne; Nicolas Régenet; Jianhua Wang; Frédéric Oberti; Frédéric Moal; Jerôme Roux; Yves Gallois; Sophie Michalak; Paul Calès
Journal:  Hepatol Int       Date:  2008-04-12       Impact factor: 6.047

2.  Hemodynamic assessment of the development of portal-systemic collaterals in portal hypertensive rats.

Authors:  Che-Chang Chan; Shiow-Chwen Tsai; Ling-Yi Cheng; Fa-Yauh Lee; Han-Chieh Lin
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

3.  Hemodynamic effects of acute and chronic administration of vapreotide in rats with cirrhosis.

Authors:  Nary Veal; Frédéric Moal; Frédéric Oberti; Eric Vuillemin; Paul Calés
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

4.  Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

Authors:  Frédéric Moal; Nary Veal; Eric Vuillemin; Eric Barrière; Jianhua Wang; Lionel Fizanne; Frédéric Oberti; Olivier Douay; Yves Gallois; Dominique Bonnefont-Rousselot; Marie Christine Rousselet; Paul Calès
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.